| Affinity chromatography as a tool for antibody purification BV Ayyar, S Arora, C Murphy, R O’Kennedy Methods 56 (2), 116-129, 2012 | 267 | 2012 |
| Coming-of-Age of Antibodies in Cancer Therapeutics BV Ayyar, S Arora, R O’Kennedy Trends in Pharmacological Sciences 37 (12), 1009-1028, 2016 | 111 | 2016 |
| Affinity chromatography: A versatile technique for antibody purification S Arora, V Saxena, BV Ayyar Methods 116, 84-94, 2017 | 110 | 2017 |
| Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges MK Estes, K Ettayebi, VR Tenge, K Murakami, U Karandikar, SC Lin, ... Viruses 11 (7), 638, 2019 | 106 | 2019 |
| Bile acids and ceramide overcome the entry restriction for GII. 3 human norovirus replication in human intestinal enteroids K Murakami, VR Tenge, UC Karandikar, SC Lin, S Ramani, K Ettayebi, ... Proceedings of the National Academy of Sciences 117 (3), 1700-1710, 2020 | 82 | 2020 |
| New insights and enhanced human norovirus cultivation in human intestinal enteroids K Ettayebi, VR Tenge, NW Cortes-Penfield, SE Crawford, FH Neill, ... Msphere 6 (1), 10.1128/msphere. 01136-20, 2021 | 73 | 2021 |
| Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids SC Lin, L Qu, K Ettayebi, SE Crawford, SE Blutt, MJ Robertson, XL Zeng, ... Proceedings of the National Academy of Sciences 117 (38), 23782-23793, 2020 | 72 | 2020 |
| Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection K Haga, K Ettayebi, VR Tenge, UC Karandikar, MA Lewis, SC Lin, ... mBio 11 (2), e00251-20, 2020 | 65 | 2020 |
| Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends S Hearty, PJ Conroy, BV Ayyar, B Byrne, R O’Kennedy Expert Review of Vaccines 9 (6), 645-664, 2010 | 51 | 2010 |
| Comparison of Microneutralization and Histo-Blood Group Antigen–Blocking Assays for Functional Norovirus Antibody Detection RL Atmar, K Ettayebi, BV Ayyar, FH Neill, RP Braun, S Ramani, MK Estes The Journal of infectious diseases 221 (5), 739-743, 2020 | 49 | 2020 |
| Optimizing Antibody Expression: The Nuts and Bolts BV Ayyar, S Arora, SS Ravi Methods 116, 51-62, 2017 | 46 | 2017 |
| Facile domain rearrangement abrogates expression recalcitrance in a rabbit scFv BV Ayyar, S Hearty, R O’Kennedy Applied Microbiology and Biotechnology 99 (6), 2693-2703, 2015 | 26 | 2015 |
| Affinity Chromatography for Antibody Purification S Arora, BV Ayyar, R O’Kennedy Protein Downstream Processing: Design, Development and Application of High …, 2014 | 23 | 2014 |
| The C-Terminal Heavy-Chain Domain of Botulinum Neurotoxin A Is Not the Only Site That Binds Neurons, as the N-Terminal Heavy-Chain Domain Also Plays a Very Active Role in Toxin … BV Ayyar, KR Aoki, MZ Atassi Infection and Immunity 83 (4), 1465-1476, 2015 | 21 | 2015 |
| Highly sensitive recombinant antibodies capable of reliably differentiating heart-type fatty acid binding protein from noncardiac isoforms BV Ayyar, S Hearty, R O’Kennedy Analytical biochemistry 407 (2), 165-171, 2010 | 21 | 2010 |
| Antibody–Based Biosensors for Detection of Veterinary Viral Pathogens BV Ayyar, S Arora Advances in Animal and Veterinary Sciences 1 (4S), 37-44, 2013 | 19 | 2013 |
| Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin BV Ayyar, RB Tajhya, C Beeton, MZ Atassi Scientific Reports 5, 15776, 2015 | 15 | 2015 |
| CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection BV Ayyar, K Ettayebi, W Salmen, UC Karandikar, FH Neill, VR Tenge, ... Nature Communications 14 (1), 1148, 2023 | 12 | 2023 |
| A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity W Salmen, L Hu, M Bok, N Chaimongkol, K Ettayebi, SV Sosnovtsev, ... Nature Communications 14 (1), 6516, 2023 | 6 | 2023 |
| Development of humanized scFv antibody fragment (s) that targets and blocks specific HLA alleles linked to myasthenia gravis BV Ayyar, MZ Atassi Applied Microbiology and Biotechnology 101 (22), 8165-8179, 2017 | 6 | 2017 |
Sushrut AroraLaboratory Manager at Mesoblast Inc.在 mesoblast.com 的电子邮件经过验证
